230 related articles for article (PubMed ID: 6280028)
41. Ketoconazole - a new antifungal agent.
S Afr Med J; 1983 Apr; 63(15):557. PubMed ID: 6302926
[No Abstract] [Full Text] [Related]
42. Laboratory and clinical assessment of ketoconazole in deep-seated mycoses.
Drouhet E; Dupont B
Am J Med; 1983 Jan; 74(1B):30-47. PubMed ID: 6295150
[TBL] [Abstract][Full Text] [Related]
43. Activity of SM-4470, a new imidazole derivative, against experimental fungal infections.
Ichise K; Tanio T; Saji I; Okuda T
Antimicrob Agents Chemother; 1986 Sep; 30(3):366-9. PubMed ID: 3777903
[TBL] [Abstract][Full Text] [Related]
44. [Use of topical antifungal agents in Spain].
Alou Cervera L; Maestre Vera JR; Moreno Ubeda RM;
Rev Esp Quimioter; 2001 Dec; 14(4):340-4. PubMed ID: 11856979
[No Abstract] [Full Text] [Related]
45. Ketoconazole therapy for fungal urinary tract infections.
Graybill JR; Galgiani JN; Jorgensen JH; Strandberg DA
J Urol; 1983 Jan; 129(1):68-70. PubMed ID: 6298476
[TBL] [Abstract][Full Text] [Related]
46. Therapy of common superficial fungal infections.
Huang DB; Ostrosky-Zeichner L; Wu JJ; Pang KR; Tyring SK
Dermatol Ther; 2004; 17(6):517-22. PubMed ID: 15571501
[TBL] [Abstract][Full Text] [Related]
47. Treatment of systemic mycoses in dogs.
Richardson RC; Jaeger LA; Wigle W
J Am Vet Med Assoc; 1983 Aug; 183(3):335-6. PubMed ID: 6309723
[No Abstract] [Full Text] [Related]
48. Ketoconazole.
Hay R
Br Med J (Clin Res Ed); 1982 Aug 28-Sep 4; 285(6342):584-5. PubMed ID: 6297655
[No Abstract] [Full Text] [Related]
49. Ideal properties of a modern antifungal agent--the therapy of mycoses with clotrimazole.
Oberste-Lehn H
Postgrad Med J; 1974 Jul; 50 Suppl 1():51-3. PubMed ID: 4282870
[No Abstract] [Full Text] [Related]
50. Candidiasis (vulvovaginal).
Marrazzo J
Clin Evid; 2003 Jun; (9):1980-93. PubMed ID: 15366173
[No Abstract] [Full Text] [Related]
51. Ketoconazole in systemic mycoses.
Hoeprich PD
Ann Intern Med; 1983 Jan; 98(1):105. PubMed ID: 6293360
[No Abstract] [Full Text] [Related]
52. Apparent ketoconazole failure in candidal cholecystitis.
Brooks BJ; Williams WL; Sanders CV; Marier RL
Arch Intern Med; 1982 Oct; 142(10):1934-5. PubMed ID: 6289764
[TBL] [Abstract][Full Text] [Related]
53. Managing fungal infections.
Hay RJ
Br J Hosp Med; 1984 Apr; 31(4):278-82. PubMed ID: 6722386
[No Abstract] [Full Text] [Related]
54. Candidiasis (vulvovaginal).
Spence D
Clin Evid; 2003 Dec; (10):2044-57. PubMed ID: 15555192
[No Abstract] [Full Text] [Related]
55. [Recurrent vulvovaginal mycoses].
Salvat J; Romand P; Vincent-Genod A; Younes B; Guilbert M
Rev Fr Gynecol Obstet; 1995 Nov; 90(11):494-501. PubMed ID: 8638082
[TBL] [Abstract][Full Text] [Related]
56. Ketoconazole and fungal CAPD peritonitis.
Chapman JR; Warnock DW
Lancet; 1983 Aug; 2(8348):510-1. PubMed ID: 6136662
[No Abstract] [Full Text] [Related]
57. [Action mechanism and resistance of drugs used in visceral mycoses].
Arai T
Nihon Rinsho; 1980 Nov; 38(11):4393-402. PubMed ID: 6265662
[No Abstract] [Full Text] [Related]
58. Advances in topical and systemic antifungals.
Zhang AY; Camp WL; Elewski BE
Dermatol Clin; 2007 Apr; 25(2):165-83, vi. PubMed ID: 17430754
[TBL] [Abstract][Full Text] [Related]
59. Treatment of chronic dermatophyte infections. The use of ketoconazole in griseofulvin treatment failures.
Hay RJ; Clayton YM
Clin Exp Dermatol; 1982 Nov; 7(6):611-7. PubMed ID: 6295667
[No Abstract] [Full Text] [Related]
60. [Therapy of a Candida infection with ketoconazole].
Rempen A
Med Welt; 1983 Mar; 34(10):308-9. PubMed ID: 6302435
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
